TY  - GEN
AU  - Vilsbøll,T
AU  - Garber,A J
TI  - Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide
SN  - 1463-1326
PY  - 2012///0509
KW  - Blood Glucose
KW  - drug effects
KW  - Blood Pressure
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Female
KW  - Glucagon-Like Peptide 1
KW  - analogs & derivatives
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Humans
KW  - Hypertension
KW  - Incretins
KW  - metabolism
KW  - Insulin-Secreting Cells
KW  - Liraglutide
KW  - Male
KW  - Neuroprotective Agents
KW  - pharmacology
KW  - Receptors, Glucagon
KW  - agonists
KW  - Weight Loss
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1111/j.1463-1326.2012.01579.x
ER  -